Disease Modeling and Therapeutics (DMT) 2025

Theme: Stem Cells, Organoids, and Animal Models in Translational Medicine
Dates: 29–30 September 2025
Workshops: 1–2 October 2025
Venue: Qatar National Convention Centre (QNCC), Doha, Qatar
Format: In-person Conference with Hands-on Workshops

Overview

The Disease Modeling and Therapeutics (DMT) Conference 2025 brought together leading experts in stem cell biology, organoid systems, and animal disease models to advance translational medicine. Hosted by Sidra Medicine, the conference focused on bridging basic science discoveries with clinical applications, accelerating therapeutic innovation, and improving patient outcomes.

DMT 2025 highlighted how advanced disease models—including induced pluripotent stem cells (iPSCs), organoids, zebrafish, rodent, and invertebrate systems—are transforming our understanding of disease mechanisms and enabling precision therapeutic strategies. Through keynote lectures, panel discussions, and interactive sessions, the conference fostered interdisciplinary collaboration across biomedicine and biotechnology.

Conference Themes

The scientific program centered on key pillars of translational research:

• Stem cell-based disease modeling and regenerative therapeutics
• Organoid platforms for mechanistic discovery and drug testing
• Animal models in rare and complex disease research
• Genome editing and CRISPR-based technologies
• Advanced imaging and functional genomics
• Personalized medicine approaches informed by disease modeling

These themes reflected Sidra Medicine’s commitment to integrating genomic discovery, cellular modeling, and clinical translation.

Program Highlights

DMT 2025 featured two days of plenary sessions, thematic scientific tracks, and expert panels.

Stem Cell-Based Disease Models

Sessions explored stem cell-derived therapies for diabetes, immune protection in transplantation, iPSC modeling of monogenic diseases, and GMP manufacturing of cell-based therapies.

Neurological and Complex Disorders

Presentations examined organoid and neuronal models for Parkinson’s disease, autism spectrum disorders, epilepsy, and neurodegeneration.

Organoid and Tissue Modeling

Speakers discussed engineered human organoids for intestinal, renal, hepatic, and neurodevelopmental research, along with their applications in drug screening and mechanistic studies.

Animal Models in Translational Research

The program highlighted zebrafish, rodent, Drosophila, C. elegans, and non-human primate models for rare disease discovery, functional validation, and therapeutic development.

A multidisciplinary panel discussion concluded the conference, addressing the future of disease modeling in precision medicine.

Workshops

Two parallel hands-on workshops were conducted on 1–2 October 2025 at Sidra Medicine:

Animal Disease Models Workshop

Participants engaged in theoretical sessions and practical training focused on zebrafish-based disease modeling, microinjection techniques, cardiovascular and behavioral imaging, CRISPR applications, and advanced data analysis.

iPSC Technology Workshop

This immersive workshop provided foundational and advanced training in pluripotent stem cell biology, CRISPR/Cas9 genome editing, reprogramming somatic cells, differentiation into pancreatic, hepatic, and neuronal lineages, and functional assessment of disease-relevant cell types.

These workshops strengthened technical capacity and promoted translational research skills across the regional biomedical community.

Learning Objectives

At the conclusion of DMT 2025, participants were able to:

• Evaluate the strengths and limitations of various disease modeling platforms.
• Apply stem cell and organoid technologies to translational research questions.
• Understand genome editing workflows in cellular models.
• Integrate imaging and functional genomics tools into disease studies.
• Explore pathways for translating experimental models into therapeutic innovation.

Scientific Impact

DMT 2025 reinforced Sidra Medicine’s leadership in translational biomedical research by fostering collaboration between scientists, clinicians, and industry innovators. The conference advanced regional capacity in disease modeling technologies and strengthened the bridge between laboratory discovery and clinical implementation.

By integrating stem cell biology, organoid systems, and animal models, DMT 2025 contributed to shaping the future of precision therapeutics and translational medicine in Qatar and beyond.